Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2684

Actual shortage: 240 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2435 (91%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

27 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
FENTORA 600MCG TABLET (EFFERVESCENT) Resolved 2021-03-04 2021-03-18 135114
FENTORA 200MCG TABLET (EFFERVESCENT) Resolved 2021-07-08 2021-10-14 142198
FENTORA 400MCG TABLET (EFFERVESCENT) Resolved 2021-09-23 2021-10-28 146115
FENTORA 800MCG TABLET (EFFERVESCENT) Resolved 2021-09-23 2021-10-28 146125
FENTORA 400MCG TABLET (EFFERVESCENT) Resolved 2023-04-27 2023-06-21 190698
FENTORA 600MCG TABLET (EFFERVESCENT) Resolved 2023-06-08 2023-10-04 194172
FENTORA 600MCG TABLET (EFFERVESCENT) Resolved 2023-06-19 2023-07-05 195548
FENTORA 800MCG TABLET (EFFERVESCENT) Actual shortage 2024-05-03 2024-05-03 226942
FENTORA 800MCG TABLET (EFFERVESCENT) Resolved 2024-05-09 2024-05-16 227506
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2017-08-01 2018-05-11 17844
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2019-09-26 2019-10-04 94825
TEVA-DICLOFENAC EC 25MG TABLET (ENTERIC-COATED) Avoided shortage 2019-11-21 2020-07-10 99453
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2020-03-26 2020-05-08 109583
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2020-09-24 2020-10-22 124986
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2021-01-28 2021-04-08 132672
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2021-05-06 2021-06-10 138904
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2021-06-24 2021-07-15 141463
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2021-08-27 2021-09-23 144726
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2021-09-16 2022-04-21 145780
TEVA-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2021-10-14 2022-02-17 147219

Showing 2521 to 2540 of 2684

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852
ACT CLOPIDOGREL Discontinued 2018-10-19 2018-10-19 65065
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65284
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65289
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-12 2018-10-12 63943
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-19 2018-10-19 64891
TEVA-TECNAL C 1/4 330MG 50MG 15MG 40MG CAPSULE Discontinued 2019-04-11 2019-04-11 81353

Showing 21 to 40 of 250